Understand an Entire Technology Landscape.
Make Better Decisions. Faster.
Explore patents, scientific literature, clinical trials, companies, market intelligence, licensing, and news—all through one AI-powered platform built for your technology domain.
Purpose-built intelligence platforms for high-impact technology domains.
Built for |
Purpose-Built Intelligence Platforms
Deep, domain-specific technology and competitive intelligence platforms.
GLP-1 Ecosystem Intelligence Platform
Comprehensive pipeline, patent landscapes, and competitive dynamics across incretin mimetics, multi-agonists, and oral small molecules.
The most comprehensive intelligence platform for the incretin (GLP-1) space.
ADC (Antibody-Drug Conjugates) Intelligence
Connected intelligence tracking antibody targets, linkers, payloads, clinical combinations, and patent estates across oncology.
PD-1/PD-L1 Inhibitors Intelligence
Full-spectrum landscape of immune checkpoint inhibitors, combination therapies, bispecifics, and patent expiry cliffs.
Solid-State Battery Intelligence
Global IP filings, electrolyte chemistry breakthroughs, manufacturing readiness, and OEM commercialization pathways.
Custom Technology Intelligence
Build a dedicated, custom intelligence platform tailored to your specific technology domain or therapeutic class.
Why Teams Choose NeurOrbis
Five reasons research, IP, and strategy teams trust NeurOrbis as their connected intelligence layer.
Multi-Source Intelligence
Patents, literature, trials, companies, market & news in one place
Expert-Curated & AI-Powered
Expert curation with advanced AI for deeper, faster insights
Always Up-to-Date
Continuous monitoring across global sources
Actionable Insights
From data to decisions that drive impact
Secure & Enterprise Ready
Role-based access, SSO & data security
From Fragmented Research to
Connected Intelligence
NeurOrbis unifies the world's most critical intelligence sources and transforms disconnected data into insights that drive better decisions, faster.
Fragmented. Manual. Time-consuming.
Connected. AI-Powered. Always Current.
Ask Your Technology Anything
Explore patents, scientific literature, clinical trials, market intelligence, companies, licensing, and news through one AI-powered research assistant. Every answer is connected to its supporting evidence.
Ask a question about any technology...
Try these questions
Data Sources
Several companies are actively developing oral GLP-1 therapies. Novo Nordisk currently leads with commercialized oral semaglutide, while Eli Lilly, Pfizer and Structure Therapeutics are exploring differentiated approaches.
Recent patent filings indicate increasing activity around oral delivery technologies, absorption enhancers and combination therapies.
Evidence Mix
Generated using evidence from six connected intelligence sources.
Answers are generated using connected intelligence across multiple data sources.
Every insight is traceable to its supporting evidence.
Built for Every Innovation Team
Whether you're discovering new technologies, protecting innovation, evaluating investments, or monitoring competitors, NeurOrbis delivers connected intelligence tailored to your role.
Accelerate Discovery. Find What's Next.
Identify emerging technologies, validate scientific hypotheses, uncover white-space opportunities, and prioritize high-impact innovations using connected intelligence across patents, literature, trials, market and competitive data.
Key Questions We Answer
- What technologies and mechanisms are growing fastest?
- Which problems remain unsolved?
- Which solutions are gaining traction?
- What does the competitive landscape look like?
- Which companies and research groups are leading innovation?
Outcomes You Achieve
- Prioritize high-potential R&D programs
- Accelerate early-stage discovery
- Reduce duplication of research
- Stay ahead of scientific trends
- Build stronger innovation pipelines
Connected Intelligence Sources
Smarter Decisions
- Discover breakthrough opportunities
- Monitor emerging technologies
- Identify white-space
- Validate scientific direction
- Reduce research risk
Stop guessing.
Start knowing.
Get a personalised 30-minute walkthrough of Neurorbis — built around your team's technology domain, research priorities, and IP strategy.
Connecting patents, scientific literature, clinical trials, companies, market intelligence, and news into one AI-powered technology intelligence platform.